Markets:

Overview

News

Currencies

International

Treasuries

Evogene Ltd. - Ordinary Shares (NQ:EVGN)

0.6849 +0.0539 (+8.54%)

Streaming Delayed Price Updated: 10:22 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Evogene Ltd. - Ordinary Shares

< Previous 1 2 3 4 Next >

EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024 ↗

May 23, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023 ↗

March 07, 2024

EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party' ↗

March 07, 2024

Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported...

Via Benzinga

Topics Cannabis

Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challenges ↗

November 16, 2023

Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.

Via Benzinga

Topics Cannabis

Recap: Evogene Q3 Earnings ↗

November 15, 2023

Via Benzinga

A Preview Of Evogene's Earnings ↗

November 14, 2023

Via Benzinga

Lake Street Maintains Buy Rating for Evogene: Here's What You Need To Know ↗

August 18, 2023

Via Benzinga

Earnings Outlook For Evogene ↗

August 16, 2023

Via Benzinga

Evogene's Casterra Gets $2.2M Orders To Supply Castor Seeds ↗

July 03, 2023

Evogene Ltd. (NASDAQ: EVGN) said its unit Casterra Ag Ltd.

Via Benzinga

Earnings Scheduled For March 7, 2024 ↗

March 07, 2024

Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.

Via Benzinga

Evogene Earnings Preview ↗

March 06, 2024

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 2, 2023 ↗

October 02, 2023

Via Benzinga

Why Evogene Shares Are Moving ↗

September 21, 2023

Evogene Ltd (NASDAQ: EVGN) shares are trading lower by 5.9% to $0.63 Thursday morning after the company received a letter from the Nasdaq indicating that the company is not in compliance with the...

Via Benzinga

Israeli Cannabis Co. Reports Solid Q2 Performance, Nearing Growth Targets ↗

August 17, 2023

Cannabis company Evogene Ltd.

Via Benzinga

Topics Cannabis

Why Evogene Stock Is Tanking Today ↗

July 17, 2023

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) shares were trading 20% lower at $1.12 per share at the time of writing Monday morning.

Via Benzinga

TalkMarkets Announces Company Spotlight Featuring Evogene ↗

June 22, 2023

TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.

Via Talk Markets

Evogene: Q1 Earnings Insights ↗

May 18, 2023

Via Benzinga

Evogene's Earnings Outlook ↗

May 17, 2023

Via Benzinga

Why Acumen Pharmaceuticals Shares Are Trading Higher By Over 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 17, 2023

Gainers ProMIS Neurosciences, Inc. (NASDAQ: PMN) shares jumped 126.6% to $6.37. ProMIS showcased preclinical data at the Alzheimer's Association International Conference 2023 on computationally-derived...

Via Benzinga

Why Aehr Test Systems Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 14, 2023

Gainers Ainos, Inc. (NASDAQ: AIMD) shares surged 108.2% to $1.52 in pre-market trading after gaining around 7% on Thursday.

Via Benzinga

TalkMarkets Announces Company Spotlight Featuring Evogene

June 22, 2023

TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech (agricultural technology) and bio-tech company with a computational predictive biological platform...

Via TheNewswire.com

TalkMarkets Announces Company Spotlight Featuring Evogene

June 22, 2023

TalkMarkets.com announces a company spotlight series featuring Evogene (NASDAQ: EVGN), an agri-tech and bio-tech company with a computational predictive biological platform technology.

Via News Direct

Evogene - A Company With Valuable Assets Trading At Zero Enterprise Value ↗

June 22, 2023

From a sum-of-parts perspective, Evogene is likely worth many multiples of its market valuation today, even without ascribing any value to Evogene’s technology.

Via Talk Markets

Why ToughBuilt Industries Shares Are Trading Lower By Over 46%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

June 21, 2023

Gainers Advanced Health Intelligence Ltd. (NASDAQ: AHI) shares jumped 209.5% to $2.29 after the company signed a Letter of Intention with UAE-Based e-script medicine management company Pharmak...

Via Benzinga

Why Evogene (EVGN) Stock Is Trading Higher ↗

June 21, 2023

Evogene Ltd (NASDAQ: EVGN) shares are trading higher by 13.72% to $0.83 Wednesday morning after the company announced its subsidiary, Casterra, signed a framework agreement with an oil & gas company to...

Via Benzinga

Tryp Submits IND Application To FDA For Clinical Trial Of Psilocybin-Assisted Psychotherapy In Patients With IBS ↗

May 24, 2023

Tryp Therapeutics, Inc. (OTCQB: TRYPF) (CSE:TRYP) has submitted an Investigational New Drug application to the U.S.

Via Benzinga

Evogene Q1 Revenue Grows 170% YoY, Here Are The Details ↗

May 18, 2023

Evogene Ltd. (NASDAQ: EVGN) (TASE:EVGN) released its financial results for the first quarter period ending March 31, 2023, revealing revenues of $641,000, an increase of 170% compared to $237,000 in...

Via Benzinga

Earnings Scheduled For May 18, 2023 ↗

May 18, 2023

Companies Reporting Before The Bell • Lightspeed Commerce (NYSE:LSPD) is projected to report quarterly loss at $0.04 per share on revenue of $248.01 million.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 2, 2023 ↗

May 02, 2023

Via Benzinga

Looking To Invest In Artificial Intelligence? Consider Evogene And Its Five Subsidiaries ↗

April 27, 2023

Evogene employs an artificial intelligence platform for decoding plant phenotypes and microbial genomes. Consider its' research agenda, applications, and at-the-market products. The set-up may present...

Via Talk Markets

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.